Colite aiguë grave au cours des MICI: l’étape diagnostique

Severe colitis: diagnosis step

Résumé

Évaluer la sévérité d’une colite est un objectif important pour le clinicien parce que, de cette évaluation, dépendent les stratégies thérapeutiques médicamenteuses et l’opportunité d’un geste de colectomie en urgence pour améliorer à la fois le pronostic et la mortalité des malades souffrant de cette affection. Aucun score clinique ou d’imagerie de référence ne peut être préféré, mais la combinaison des différents critères pronostiques est utile.

Abstract

Assessment of severity of colitis remains an important goal for physicians because both adequate drug strategies and the opportunity to perform emergency colectomies to improve mortality rates and prognosis depend on this assessment. Neither clinical nor imaging score is a gold standard but combined assessment is helpful.

This is a preview of subscription content, access via your institution.

Références

  1. 1.

    Bouhnik Y, Vahedi K, Bitou NA, Matuchansky C (1998) Colites aiguës graves au cours des maladies inflammatoires chroniques de l’intestin. In: Rambaud JC (ed.) Les maladies inflammatoires chroniques de l’intestin. John Libbey Eurotext 155–174

  2. 2.

    Lavergne-Slove A (1998) Anatomopathologie. In: Rambaud JC (ed.) Les maladies inflammatoires chroniques de l’intestin. John Libbey Eurotext 11–25

  3. 3.

    Truelove SC, Witts LJ (1955) Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J 1041–1048

  4. 4.

    Truelove SC, Jewell DP (1974) Intensive intravenous regimen for severe attacks of ulcerative colitis. Lancet 1: 1067–1070

    PubMed  Article  CAS  Google Scholar 

  5. 5.

    Travis SPL, Farrant JM, Ricketts C, et al. (1996) Predicting outcome in severe ulcerative colitis. Gut 38: 905–910

    PubMed  Article  CAS  Google Scholar 

  6. 6.

    Seo M, Okada M, Yao T, et al. (1992) An index of disease activity in patients with ulcerative colitis. Am J Gastroenterol 87: 971–976

    PubMed  CAS  Google Scholar 

  7. 7.

    Seo M, Okada M, Yao T, et al. (2002) Evaluation of the clinical course of acute attacks in patients with ulcerative colitis through the use of an activity index. J Gastroenterol 37: 91–94

    Article  Google Scholar 

  8. 8.

    Lichtiger S, Present DH, Kornbluth A, et al. (1994) Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 330: 1841–1845

    PubMed  Article  CAS  Google Scholar 

  9. 9.

    Schroeder KW, Tremaine WJ, Illstrup DM (1987) Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 317: 1625–1629

    PubMed  CAS  Article  Google Scholar 

  10. 10.

    Best WR, Becktel JM, Singleton JW (1979) Rederived values of the eight coefficients of the Crohn’s disease activity index (CDAI). Gastroenterology 77: 843–846

    PubMed  CAS  Google Scholar 

  11. 11.

    Carbonnel F, Lavergne A, Lemann A, et al. (1994) Colonoscopy of acute colitis. A safe and reliable tool for assessment of severity. Dig Dis Sci 39: 1550–1557

    PubMed  Article  CAS  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to M. -A. Bigard.

About this article

Cite this article

Bigard, M.A. Colite aiguë grave au cours des MICI: l’étape diagnostique. Colon Rectum 2, 5–9 (2008). https://doi.org/10.1007/s11725-008-0070-3

Download citation

Mots clés

  • Colite aiguë grave
  • Rectocolite hémorragique
  • Maladie de Crohn
  • Colectasie

Keywords

  • Severe acute colitis
  • Ulcerative colitis
  • Crohn’s disease
  • Toxic megacolon